TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 48 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $250,000 | -53.9% | 532,455 | -31.5% | 0.00% | – |
| Q3 2016 | $542,000 | -61.5% | 777,440 | +10.0% | 0.00% | – |
| Q2 2016 | $1,407,000 | -16.2% | 707,065 | +1.5% | 0.00% | – |
| Q1 2016 | $1,678,000 | -55.3% | 696,534 | +42.3% | 0.00% | – |
| Q4 2015 | $3,755,000 | +58.1% | 489,580 | +9.1% | 0.00% | – |
| Q3 2015 | $2,375,000 | -26.9% | 448,874 | +23.9% | 0.00% | – |
| Q2 2015 | $3,250,000 | +46.5% | 362,360 | +3.2% | 0.00% | – |
| Q1 2015 | $2,218,000 | +55.5% | 350,960 | +43.7% | 0.00% | – |
| Q4 2014 | $1,426,000 | -12.2% | 244,160 | +3.0% | 0.00% | – |
| Q3 2014 | $1,624,000 | -43.4% | 237,060 | +18.6% | 0.00% | – |
| Q2 2014 | $2,869,000 | +41.7% | 199,913 | +2.8% | 0.00% | – |
| Q1 2014 | $2,025,000 | +427.3% | 194,513 | +423.0% | 0.00% | – |
| Q4 2013 | $384,000 | – | 37,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Managed Accounts LLC | 75,000 | $35,258,000 | 0.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 696,455 | $327,000 | 0.02% |
| Klingman & Associates, LLC | 10,000 | $5,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 76,500 | $36,000 | 0.00% |
| OPPENHEIMER & CO INC | 73,500 | $34,000 | 0.00% |
| Renaissance Technologies | 774,603 | $364,000 | 0.00% |
| Walleye Trading LLC | 6 | $0 | 0.00% |
| Bank of New York Mellon Corp | 16,660 | $8,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,071 | $5,000 | 0.00% |
| SIMPLEX TRADING, LLC | 200 | $0 | 0.00% |